BEND, Oregon — On a shelf of Dr. Byron Maas’ clinic in Bend, Oregon lies survey-based marijuana supplements for dogs. Maas said the products are on high demand.
The ‘Up and Moving’ is for joint and pain and the ‘Calm and Quiet’ is for getting rid of dogs’ anxiety.
Pet parents have turned to CBD-infused products to relieve their four-legged friends’ suffering; but little do they know whether it really works or if any negative side effects exist.
Inside his Bend Veterinary Clinic, Maas said his clients have reported CBDs positively helping to relieve pain, arthritis, anxiety, loss of appetite, epilepsy and inflammation in their pets. However, more research on marijuana for domesticated animals is needed.
“Unfortunately there’s not a lot of research out there, especially on animals, on CBD compounds,” Maas told Associated Press. “The research is really necessary to help us understand how to actually use these compounds on our pets.”
The blame is to the authorities.
The federal Drug Enforcement Administration said last year that cannabis extracts with CBD, either with or without THC, are a Schedule I drug. The category is defined by drugs that are illegal, has high potential of abuse and unaccepted for medical use in any treatment.
Numerous legal actions are being considered by Food and Drug Administration against companies that sell marijuana products online, at pet shops and animal hospitals. They were told that they’re violating laws by offering “unapproved new animal drugs.”
Utah Senator Orrin Hatch became an unlikely leader pushing to remove the barrier.
While firmly standing against recreational marijuana use, the conservative Republican introduced a bill in September that would open the path for more clinical research.
“We lack the science to support use of medical marijuana products like CBD oils, not because researchers are unwilling to do the work, but because of bureaucratic red tape and over-regulation,” Hatch said.